Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07457333) titled 'Beta-sitosterol for Subarachnoid Hemorrhage: Mechanistic Analysis of Recovery and Therapy' on March 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Condition:
Subarachnoid Haemorrhagic Stroke
Intervention:
Drug: Supplementation of ß -sitosterol
Recruitment Status: Recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: February 1, 2026
Target Sample Size: 40
Countries of Recruitment:
China
To ...